Thomas Jefferson University Announces Initiative to Study Health Outcomes in Medical Cannabis Patients
The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University announced the creation of the mmj.org initiative in a press release on May 17 (1). The goal of the initiative is to bring together diverse stakeholders in the cannabis therapy space, advance scientific understanding of medical marijuana and its derivatives, and provide evidence-based resources for patients and their caregivers.
According to the press release, the mmj.org initiative is a national patient registry in which more than 100,000 medical marijuana patients will share their health outcomes to drive new understanding of the safety and medical utility of cannabinoids used as therapy. The registry will be the largest and most comprehensive clinical database yet accumulated in the field of medical marijuana. Patient recruitment into the registry will start early this summer via an online platform at www.mmj.org and with partnering patient and healthcare organizations and medical marijuana dispensaries across the country.
The mmj.org initiative is being managed through a public-private partnership between The Lambert Center and ioVita, a digital health company focused on technology to connect and empower patients living with chronic diseases.
"Millions of patients with chronic diseases are seeking health benefits from marijuana and various cannabinoids, and many are left to experiment with cannabis products on their own. These patients and their caregivers not only deserve our support, but they can help advance scientific understanding by sharing their experiences in a research registry designed with rigor and scale," said Charles V. Pollack Jr., MD, director of The Lambert Center, in a press release. "The mmj.org initiative aims to tackle complex issues related to medical marijuana. To achieve this, we are focused on patient needs, rigorous science, and engagement of all stakeholders-patients, healthcare professionals, and industry-critics and advocates alike.
References:
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
